Table 1 Characteristics of the studies included in the meta-analysis.

From: The pretreatment lymphocyte to monocyte ratio predicts clinical outcome for patients with hepatocellular carcinoma: A meta-analysis

Author

Year

Country

Type of publication

Follow-up (months)

Treatment

No. of patients

Stage

Cut-off value

Survival analysis

Analysis

NOS score

Li

2017

China

Full-text

33 (6–85)

Surgery

253

Mixed

3.0

OS/RFS

MV/UV

8

Liao

2016

China

Full-text

44 (1.5–84)

Surgery

387

Mixed

3.3

OS/RFS

MV

8

Lin (1)

2015

China

Full-text

34.8 (1.7–106.6)

Surgery

210

Mixed

3.23

OS/RFS

MV/UV

7

Lin (2)

2014

China

Abstract

34 (2–106)

Surgery

210

3.2

OS/RFS

MV/UV

Tang

2016

China

Full-text

38 (1.5–82.2)

Surgery

208

Mixed

0.83

OS/RFS

MV/UV

5

Wu

2016

China

Full-text

45.5 (2–93)

Surgery

450

Mixed

3.77

OS/RFS

MV/UV

7

Yang

2017

China

Full-text

NA

Surgery

1020

Mixed

3.23

DFS

MV/UV

6

  1. OS: overall survival; DFS: disease-free survival; RFS: recurrence-free survival; MV: multivariate; UV: univariate NA: not available.